By combining the CRISPR-Cas9 system with the adenovirus recombination technique, we developed stable CAV1-knockdown (CAV1-KD) AML12 hepatocyte cell lines (Fig 2D) to determine the influence of inherent CAV1 depletion on hepatocyte steatosis. This evidence concerns the gene CAV1 and steatosis.